S&P revises UAB Medicine's outlook to negative over weaker operations

S&P Global Ratings revised Birmingham, Ala.-based UAB Medicine's outlook to negative from stable.

S&P also affirmed its "AA-" long term rating on the health system's revenue bonds.

The outlook revision is a result of UAB Medicine's weaker operating margins in the last two fiscal years, which resulted in a lowered annual debt service coverage. The new maximum annual debt service coverage is not in line with its current "AA-" long-term rating.

More articles on healthcare finance:
TransUnion Healthcare keeping contract with VA 
41 hospital, health system outlook and credit rating actions in July
Proposed physician fee changes credit negative for academic med centers, some rural hospitals, Moody's says

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.